These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 28724116

  • 1. Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
    Pagidipati NJ, Hellkamp A, Thomas L, Gulati M, Peterson ED, Wang TY.
    JAMA Cardiol; 2017 Sep 01; 2(9):1040-1042. PubMed ID: 28724116
    [Abstract] [Full Text] [Related]

  • 2. Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study.
    Tøttenborg SS, Clark AJ, Thomsen RW, Johnsen SP, Lange P.
    Int J Chron Obstruct Pulmon Dis; 2018 Sep 01; 13():1775-1781. PubMed ID: 29881267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M, Perriot J, Peiffer G, Harika-Germaneau G, Jaafari N.
    Rev Pneumol Clin; 2018 Sep 01; 74(4):205-214. PubMed ID: 29773262
    [Abstract] [Full Text] [Related]

  • 5. Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study.
    Monárrez-Espino J, Galanti MR, Hansson J, Janszky I, Söderberg-Löfdal K, Möller J.
    Nicotine Tob Res; 2018 Apr 02; 20(5):606-613. PubMed ID: 28595356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Investigating gender differences for effectiveness and side effects of varenicline during smoking cessation treatment.
    Moura H.
    Rev Assoc Med Bras (1992); 2020 May 15; 66(2):232-233. PubMed ID: 32428161
    [No Abstract] [Full Text] [Related]

  • 8. Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation.
    Yang M, Chen H, Johnson ML, Essien EJ, Peters RJ, Wang X, Abughosh S.
    Subst Use Misuse; 2016 May 15; 51(5):586-97. PubMed ID: 27007975
    [Abstract] [Full Text] [Related]

  • 9. Smoking Cessation in Patients With Acute Coronary Syndrome.
    Franck C, Filion KB, Eisenberg MJ.
    Am J Cardiol; 2018 May 01; 121(9):1105-1111. PubMed ID: 29526275
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Graham DJ, By K, McKean S, Mosholder A, Kornegay C, Racoosin JA, Young J, Levenson M, MaCurdy TE, Worrall C, Kelman JA.
    Pharmacoepidemiol Drug Saf; 2014 Nov 01; 23(11):1205-12. PubMed ID: 25044169
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM.
    JAMA Intern Med; 2018 May 01; 178(5):622-631. PubMed ID: 29630702
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
    Yang M, Chen H, Johnson ML, Essien EJ, Peters RJ, Wu IH, Abughosh SM.
    Subst Use Misuse; 2015 May 01; 50(13):1628-37. PubMed ID: 26595661
    [Abstract] [Full Text] [Related]

  • 13. Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.
    AlMulla A, Hassan-Yassoub N, Fu D, El-Awa F, Alebshehy R, Ismail M, Fraser CP.
    East Mediterr Health J; 2020 Jan 30; 26(1):110-115. PubMed ID: 32043553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Varenicline for Smoking Cessation.
    Crawford P, Cieslak D.
    Am Fam Physician; 2017 Sep 01; 96(5):Online. PubMed ID: 28925657
    [No Abstract] [Full Text] [Related]

  • 16. Effects of aging on the effectiveness of smoking cessation medication.
    Scholz J, Santos PC, Buzo CG, Lopes NH, Abe TO, Gaya PV, Pierri H, Amorim C, Pereira AC.
    Oncotarget; 2016 May 24; 7(21):30032-6. PubMed ID: 27166253
    [Abstract] [Full Text] [Related]

  • 17. Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
    Silva AP, Scholz J, Abe TO, Pinheiro GG, Gaya PV, Pereira AC, Santos PC.
    BMC Cardiovasc Disord; 2016 Jan 05; 16():2. PubMed ID: 26728720
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K, Larivière J, Eisenberg MJ, Eberg M, Gore GC, Grad R, Joseph L, Reynier PM, Filion KB.
    Circ Cardiovasc Qual Outcomes; 2017 Jan 05; 10(1):. PubMed ID: 28093398
    [Abstract] [Full Text] [Related]

  • 19. Combination bupropion SR and varenicline for smoking cessation: a systematic review.
    Vogeler T, McClain C, Evoy KE.
    Am J Drug Alcohol Abuse; 2016 Mar 05; 42(2):129-39. PubMed ID: 26809272
    [Abstract] [Full Text] [Related]

  • 20. Use of prescribed smoking cessation pharmacotherapy following release from prison: a prospective data linkage study.
    Puljević C, de Andrade D, Carroll M, Spittal MJ, Kinner SA.
    Tob Control; 2018 Jul 05; 27(4):474-478. PubMed ID: 28848000
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.